MAP2K3 and non-small cell lung carcinoma: This, in turn, inhibits the mitogen-activated protein kinase 3/Nuclear factor kappaB cells (MAPK3/NF-κB) signaling pathway, suppressing the proliferation of non-small cell lung cancer (NSCLC) cells.